Pay in 4 interest-free payments of $6.39 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
In animal models, GLP-1RAs inhibited myocardial fibrosis and reduced ventricular hypertrophy
The FDA approved oral semaglutide 25 mg, also known as the Wegovy pill, making it the first GLP-1 tablet approved specifically for obesity
The GLP-1 agonists drugs market report also covers current unmet needs and challenges while incorporating new classes in treatment paradigm, variations in accessibility and acceptability of new Glucagon-like Peptide-1 (GLP-1) Agonists in different geographies, along with insights on Glucagon-like Peptide-1 (GLP-1) Agonists pricing reimbursements to curate the best opportunities and assess the markets potential
A newer high-dose version called Wegovy HD, containing 7.2 mg of semaglutide, was approved for patients whose weight loss stalls on the standard 2.4 mg dose
